Medicine Supply Notification: Quinapril (Accupro® ) 5mg, 10mg, 20mg and 40mg tablets
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Quinapril (Accupro®) 5mg, 10mg, 20mg and 40mg tablets.
MSN/2022/041
Tier 2 – medium impact
Date of issue 5th May 2022
- All strengths of quinapril (Accupro®) tablets have been recalled with a resupply date to be confirmed. Pfizer are the sole supplier of quinapril tablets in the UK
- Alternative ACE inhibitors remain available and can support an uplift in demand.
A copy of this medicine supply notification, including further information, has been sent to all pharmacy NHS email addresses.
DHSC and NHSE/I have now launched an online Medicines Supply Tool, which provides up to date information about medicine supply issues. The contents of these MSNs can now be viewed on the Tool.
The Tool also details any changes to resupply dates and updates to the entries.
To access the Tool you will need an NHS email address. Once set up and logged in, you will be able to access it online.
New shortages not listed on the SPS website, can be reported using our shortage reporting tool.
